These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The use of fluorocarbon emulsions in cancer radiotherapy. Guichard M Radiother Oncol; 1991; 20 Suppl 1():59-64. PubMed ID: 2020771 [TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%). Tremper KK; Lapin R; Levine E; Friedman A; Shoemaker WC Crit Care Med; 1980 Dec; 8(12):738-41. PubMed ID: 7449405 [TBL] [Abstract][Full Text] [Related]
7. Recent studies on perfluorochemical (PFC) emulsion as an oxygen carrier in Japan. Mitsuno T; Ohyanagi H; Yokoyama K; Suyama T Biomater Artif Cells Artif Organs; 1988; 16(1-3):365-73. PubMed ID: 3052644 [TBL] [Abstract][Full Text] [Related]
8. Perfluorochemical artificial blood as a volume expander in hypoxemic respiratory failure in dogs. Light RB; Perez-Padilla R; Kryger MH Chest; 1987 Mar; 91(3):444-9. PubMed ID: 3816321 [TBL] [Abstract][Full Text] [Related]
9. Development of a perfluorochemical emulsion as a blood gas carrier. Mitsuno T; Ohyanagi H; Yokoyama K Artif Organs; 1984 Feb; 8(1):25-33. PubMed ID: 6422912 [TBL] [Abstract][Full Text] [Related]
10. Fluorocarbon-based in vivo oxygen transport and delivery systems. Riess JG Vox Sang; 1991; 61(4):225-39. PubMed ID: 1776239 [TBL] [Abstract][Full Text] [Related]
11. The influence of oxygenation on the 19F spin-lattice relaxation rates of fluosol-DA. Reid RS; Koch CJ; Castro ME; Lunt JA; Treiber EO; Boisvert DJ; Allen PS Phys Med Biol; 1985 Jul; 30(7):677-86. PubMed ID: 4023055 [TBL] [Abstract][Full Text] [Related]
12. Present status of clinical studies of Fluosol-DA (20%) in Japan. Mitsuno T; Ohyanagi H Int Anesthesiol Clin; 1985; 23(1):169-84. PubMed ID: 3980104 [TBL] [Abstract][Full Text] [Related]
13. O2 and CO2 solubility of the fluorocarbon emulsion fluosol-DA 20% and O2 and CO2 dissociation curves of blood-fluosol-DA 20% mixtures. Grote J; Steuer K; Müller R; Söntgerath C; Zimmer K Adv Exp Med Biol; 1985; 191():453-61. PubMed ID: 3938602 [No Abstract] [Full Text] [Related]
14. Critical oxygen delivery levels during shock following normoxic and hyperoxic haemodilution with fluorocarbons or dextran. Faithfull NS; Cain SM Adv Exp Med Biol; 1987; 215():79-87. PubMed ID: 2445179 [TBL] [Abstract][Full Text] [Related]
15. Red cell substitutes: an update. Gould SA; Sehgal LR; Rosen AL; Sehgal HL; Moss GS Ann Emerg Med; 1985 Aug; 14(8):798-803. PubMed ID: 4025972 [TBL] [Abstract][Full Text] [Related]
16. Biocompatibility studies with a novel perfluorochemical emulsion. Bollands AD; Lowe KC; Sharma SK; Davis SS Biomater Artif Cells Artif Organs; 1988; 16(1-3):451-3. PubMed ID: 3179482 [TBL] [Abstract][Full Text] [Related]
17. Human albumin binding of tamoxifen in the presence of a perfluorochemical erythrocyte substitute. Shah IG; Parsons DL J Pharm Pharmacol; 1991 Nov; 43(11):790-3. PubMed ID: 1686908 [TBL] [Abstract][Full Text] [Related]
18. A perfluorochemical emulsion as an oxygen carrier. Yokoyama K; Suyama T; Okamoto H; Watanabe M; Ohyanagi H; Saitoh Y Artif Organs; 1984 Feb; 8(1):34-40. PubMed ID: 6703924 [TBL] [Abstract][Full Text] [Related]
19. The effects of fetal exchange transfusion with a red blood cell substitute. Ambrose A; Cefalo RC; Bowes WA Am J Obstet Gynecol; 1986 Mar; 154(3):667-74. PubMed ID: 3082209 [TBL] [Abstract][Full Text] [Related]
20. Whole body oxygenation using intraperitoneal perfusion of fluorocarbons. Faithfull NS; Klein J; van der Zee HT; Salt PJ Br J Anaesth; 1984 Aug; 56(8):867-72. PubMed ID: 6430312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]